News tagged with carcinoma cells
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Feb 09, 2012 |
5 / 5 (1) |
0
Combination drug therapy urged to battle lung cancer
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI).
Feb 02, 2012 |
not rated yet |
0
FDA approves new skin cancer drug
A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable ...
Feb 01, 2012 |
not rated yet |
0
Four-week vaccination regimen knocks out early breast cancer tumors, researchers find
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete ...
Jan 30, 2012 |
5 / 5 (4) |
0
|
FDA approves Roche skin cancer drug Erivedge
(AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.
Medicine & Health / Medications
Jan 30, 2012 |
not rated yet |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medicine & Health / Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Grape seed extract kills head and neck cancer cells, leaves healthy cells unharmed
Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.
Jan 27, 2012 |
4.9 / 5 (52) |
18
|
Prevalence of oral HPV infection higher among men than women
The overall prevalence of oral human papillomavirus (HPV) infection is approximately 7 percent among men and women ages 14 to 69 years in the United States, while the prevalence among men is higher than among women, according ...
Jan 26, 2012 |
not rated yet |
0
Lead blood levels may increase smokers' risk for kidney cancer
Higher than normal levels of lead in the blood may signal a risk two times higher than average of developing renal cell carcinoma in smokers, according to medical researchers.
Jan 23, 2012 |
not rated yet |
0
|
Study uncovers mechanism by which melanoma drug accelerates secondary skin cancers
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA's ...
Jan 18, 2012 |
5 / 5 (1) |
0
|
New indicator may help identify patients with increased risk from throat cancer
Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies.
Jan 16, 2012 |
not rated yet |
0
|
Major variation in bladder cancer subtype trends highlights need for focused research
Researchers are being urged to differentiate between two types of bladder cancer when they carry out studies, after a detailed trends analysis revealed significant differences between the main subtypes of the disease.
Jan 04, 2012 |
not rated yet |
0
New findings provide more complete picture of kidney cancer
Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.
Dec 29, 2011 |
5 / 5 (1) |
0
Study sheds light on cancer burden in Australia
Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily decreased. Those are some of the findings of a recent study published early online in the Asia-Pacific Jo ...
Dec 08, 2011 |
not rated yet |
0
FDA panel backs Pfizer drug for kidney cancer
(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
Medicine & Health / Medications
Dec 07, 2011 |
not rated yet |
0
